Join our daily newsletter At The Bell to receive exclusive market insights
- Respiri (RSH) has partnered with the University of Edinburgh in a new data research centre ahead of wheezo’s European launch
- wheezo is an asthma management device which can detect the presence of wheezing in people with asthma before they can
- The centre will use data collected by the wheezo ecosystem, to improve the delivery of care for people with respiratory conditions
- Respiri will work with BREATHE, one of seven new hubs, to expand its patient experience program to the UK before the launch into Europe next year
- Company shares remain flat and are trading for 8.6 cents each
Respiri (RSH) has partnered with the University of Edinburgh in a new data research centre to improve the health of those living with respiratory conditions.
Primary care academic and epidemiologist, Professor Aziz Sheikh, leads the BREATHE – Health Data Research Hub for Respiratory Health.
“Our partner, Professor Sheikh and his team at the hub intend to be at the forefront of digitally-enabled respiratory health, and we are honoured to be a part of it,” Respiri CEO and Managing Director Marjan Mikel said.
The centre will use data, such as that collected by Respiri’s wheezo ecosystem, to improve the delivery of care for people with asthma, chronic obstructive pulmonary disease and respiratory infections.
wheezo is an asthma management device which can detect the presence of wheezing in people with asthma before they notice it.
BREATHE is one of seven new hubs led by Health Data Research UK (HDR UK). It is also part of a four-year £37 million (roughly A$66.8 million) investment from the Government Industrial Strategy Challenge Fund (ISCF) led by UK Research and Innovation.
Respiri will work with BREATHE to expand its patient experience program to the UK. This aligns with Respiri’s strategy to enter the European market in 2021. However, this will come after the company’s commercial launch in Australia in the 2020 December quarter.
“The timing is perfect for Respiri as we now have CE mark, clearing wheezo for our European commercial launch in 2021,” Marjan said.
Company shares remain flat and are trading for 8.6 cents each at 10:17 am AEST.
